Proximagen Company
Proximagen is a neuroscience research company developing drugs for neurodegenerative disorders, including Parkinson’s and Alzheimers.
Total Funding:
$96.5M
Headquarters:
London, England, United Kingdom
Funding Status:
N/A
Employee Number:
11-50
Estimated Revenue:
$1M to $10M
Investment Stage:
N/A
Last Funding Type:
Venture - Series Unknown
Number Of Exists:
Venture - Series Unknown
Technology:
Others
Investor Type:
Company
Investors Number:
1
Founded Date:
2003
Industry:
PharmTech